ATF4-activated parkin induction contributes to deferasirox-mediated cytoprotection in Parkinson’s disease

Sangwoo Ham(Samsung (South Korea)), Yunjong Lee(Samsung Medical Center)
Toxicological Research
December 8, 2022
Cited by 8


Related Papers